UNSPSC 51421504: Fluticasone furoate

This classification denotes a therapeutic glucocorticoid, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier JS86977WNV. European Medicines Agency schedules Fluticasone furoate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB26593. Fluticasone furoate generally arises in the molecular formula C27H29F3O6S.

UNSPSC 51421504 Fluticasone furoate is a Commodity code that nominally covers a specific inhaled corticosteroid medication, but the available recent state and local procurement activity shows no alignment with this pharmaceutical product. The single identified opportunity—Seminole County, Florida's IFB for naloxone and drug deactivation systems—falls outside the scope of fluticasone furoate procurement and instead addresses opioid-overdose response and harm-reduction supplies. State and local health departments, counties, and municipalities that might use this code typically procure respiratory medications through group purchasing organizations, cooperative purchasing vehicles, or direct health-system contracts rather than through competitive sealed bidding.

Seminole County, Florida posted IFB 60459723LAS on June 30, 2026, with a response deadline of July 26, 2023, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford. The contract carries a two-year initial term with one-year renewal option, E-Verify and drug-free workplace certification requirements, and potential FEMA funding with associated federal compliance obligations including the Clean Air Act and Federal Water Pollution Control Act. Because the recent-opportunities block contains only this single naloxone-focused solicitation—which is unrelated to fluticasone furoate—the code shows little relevant recent activity. Business development professionals evaluating this code should verify whether their firm's fluticasone offerings align with state health-department formulary procurement, hospital-system contracts, or school nurse supply agreements, as those pathways do not appear in the current public bidding record.